Abstract

BackgroundRecently there has been a significant increase in the number of oral anti-cancer medicines (OAM) available with patient preference the primary driver behind this increase. There are associated safety concerns...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
PS-017 Using treatment protocols in the verification of oral anticancer drug prescriptions
J O’Shea ... L Hammond
European Journal of Hospital Pharmacy | VOL. 22
J O’Shea, et. al.J O’Shea ... L Hammond
01 Mar 2015
Patterns of use of oral anticancer treatments in France: a Retrospective Analysis of Cancer Treatments given ORally from 2004 to 2012 (Re-ACTOR study)
L Benjamin ... I Bardoulat
Current Medical Research and Opinion | VOL. 31
L Benjamin, et. al.L Benjamin ... I Bardoulat
24 Nov 2014
Identification of risks associated with the prescribing and dispensing of oral anticancer medicines in Ireland
Claire Keane ... Fionnuala King
International Journal of Clinical Pharmacy | VOL. 34
Claire Keane, et. al.Claire Keane ... Fionnuala King
09 Sep 2012
Oral anticancer medicine interventions: A cross-sectional study in French community pharmacies.
Florent Macé ... Pauline Pistre
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | VOL. -
Florent Macé, et. al.Florent Macé ... Pauline Pistre
07 Mar 2024
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
EAHP and GS1 publish report of UZ Leuven meeting on bedside scanning and medicines bar coding
Richard Price
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Richard PriceRichard Price
19 May 2014
In peer review we trust—or do we?
Phil Wiffen
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil WiffenPhil Wiffen
19 May 2014
European Parliament Committee approves €3 billion public-private partnership with industry on new medicine development
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
19 May 2014
Chapter 5: Appraising the evidence
Phil Wiffen ... Hao Lu
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil Wiffen, et. al.Phil Wiffen ... Hao Lu
19 May 2014
View more papers